The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

The BAMs have a hydrophobic inner surface to prolong microbubble retention within biofluids and a hydrophilic outer layer ...

Eating specific foods and avoiding others may help reduce your risk of gallbladder disease. A gallbladder diet is an overall ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the ...

“Yet we know there are thousands of other harmful chemicals that are not regulated that make their way into groundwater and ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced significant progress in its ongoing ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer. The University of Sheffield led the trial, alongside Barts Cancer ...